An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin.
about
Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human plateletsLow-dose aspirin for in vitro fertilization: a systematic review and meta-analysisThe mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.The combined effects of ginkgo biloba extracts and aspirin on viability of sk-N-mc, neuroblastoma cell line in hypoxia and reperfusion conditionPhysiological role of an endoperoxide in human platelets: hemostatic defect due to platelet cyclo-oxygenase deficiency.Acetylation of prostaglandin synthase by aspirinProstaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins.Vitamin E. An inhibitor of the platelet release reactionProstaglandins temporally regulate cytoplasmic actin bundle formation during Drosophila oogenesisRole of basic science in the development of new medicines: examples from the eicosanoid field.The influence of prostaglandin endoperoxides on platelet ultrastructure.Proceedings: Thrombolytic and anti-thrombotic properties of dihomo-gamma-linolenate in vitro.Proceedings: Prostaglandin D1 inhibits the increase in vascular permeability in rat skin produced by prostaglandin E1, E2 and D2.The inhibitory effect of aspirin on platelet and vascular prostaglandins in rats cannot be completely dissociated.Purification and characterization of sheep platelet cyclo-oxygenase. Acetylation by aspirin prevents haemin binding to the enzyme.A possible role of arachidonic acid in human neutrophil aggregation and degranulation.
P2860
Q24564188-47A95A48-0914-4D56-B723-037E704067C9Q28220366-904181E1-C60C-4F1E-A3C8-BE7CCD43ACA0Q34481430-4A7F7C68-10BD-47D8-B7BF-0C14D1F65A2AQ34762524-C2A88A71-43B8-4250-BD7C-6E4C0CFEBB75Q35076168-534F0279-9135-4BD7-A6B7-06B2DFA54A8EQ35085661-E3D7C911-8301-4804-8E3A-FB7F78B1010EQ35127571-00E12299-C554-4924-B1C8-2B1DD5E6AA21Q35198903-316B842B-39E8-48A3-A294-5A41F5035CFDQ37533694-E2533407-0770-4276-8D9A-9ADBF0E96490Q37982662-8DD5986A-420D-4EEE-A242-EE5343A88D71Q39950120-CB3BDF82-B3A0-4E6A-BFBD-0E3CDD11FAC6Q40009447-E3B35962-344F-4205-91CF-436A1CB39F7FQ40010646-4F8AC704-B47C-4839-96E2-F8EDDCA0B61AQ41092833-9E99E85C-80F8-4911-8AF8-943538DD18AAQ41771236-37A78B89-B7F5-482E-AEB6-E44E52641CC8Q41811890-53F6094E-5C23-43F4-8BB4-610732D68577
P2860
An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin.
description
1974 nî lūn-bûn
@nan
1974年の論文
@ja
1974年学术文章
@wuu
1974年学术文章
@zh
1974年学术文章
@zh-cn
1974年学术文章
@zh-hans
1974年学术文章
@zh-my
1974年学术文章
@zh-sg
1974年學術文章
@yue
1974年學術文章
@zh-hant
name
An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin.
@en
An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin.
@nl
type
label
An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin.
@en
An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin.
@nl
prefLabel
An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin.
@en
An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin.
@nl
P1433
P1476
An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin.
@en
P2093
P304
P356
10.1126/SCIENCE.183.4122.325
P407
P577
1974-01-01T00:00:00Z